Introduction – Understanding Joint Problems
Joint issues, whether caused by osteoarthritis or soft tissue injuries, affect up to 30% of the global population. While not directly life-threatening, these conditions can drastically reduce quality of life by limiting mobility and causing chronic pain. Age is the single most important predictor of arthritis, due to the natural wear-and-tear on cartilage over time. With an aging population and increased participation in competitive sports, joint problems are more prevalent than ever.
Soft tissue injuries, such as ligament sprains and tendon tears, are also on the rise, affecting both young athletes and older adults seeking to maintain an active lifestyle.
Osteoarthritis – Causes and Challenges
Osteoarthritis is a progressive degenerative condition that results in loss of cartilage, the tissue responsible for smooth joint movement. Cartilage naturally has poor blood circulation, which limits its ability to repair itself. Over time, cartilage deterioration leads to inflammation, pain, stiffness, and impaired joint function.
Current conventional treatments, including painkillers and anti-inflammatory drugs, manage symptoms but do not repair or restore cartilage, leaving a gap in effective long-term solutions.
Stem Cells – A Natural Solution for Joint Repair
Stem cell research has revealed that bone marrow stem cells have the remarkable ability to transform into cartilage, bone, and tendon cells. These cells can contribute directly to tissue repair in joints.
Some approaches use biodegradable scaffolds that provide a structure for stem cells to develop into chondrocytes (cartilage cells), ultimately regenerating damaged cartilage. Other methods involve direct injection of bone marrow stem cells into affected joints, sometimes combined with techniques to retain the cells in the joint and stimulate their transformation into cartilage-producing cells.
Endogenous Stem Cell Mobilization (ESCM) and Joint Repair
Beyond direct stem cell injections, research has shown that naturally mobilizing a person’s own stem cells can also support joint repair. Following injury, stem cells are released from the bone marrow and migrate to damaged tissues to aid recovery.
In clinical studies, patients who underwent ESCM reported significant improvements in joint function without the need for injected stem cells. In one notable case, a woman with severe rheumatoid arthritis regained the ability to walk and perform daily activities independently after consuming a natural stem cell enhancer over the course of one year.
Stem Cells for Soft Tissue Injuries
Tendons and ligaments contain their own tissue-specific stem cells called tendon-derived stem cells (TDSC). These cells play a key role in repairing soft tissue injuries but decline in number with age, making recovery slower in older adults.
Mesenchymal stem cells from bone marrow can supplement TDSC, helping to regenerate injured tendons and ligaments. Studies have shown that bone marrow stem cell injections can improve tendon repair, restore strength, and accelerate healing.
ESCM Enhances Recovery for Athletes
Research shows that simply stimulating the release of stem cells from bone marrow can enhance soft tissue repair. For example, professional soccer players with ankle injuries who consumed a natural stem cell enhancer experienced:
- Faster pain reduction
- Improved joint stability
- Greater range of motion
- Earlier return to play than those relying on traditional therapies
Even small increases in circulating stem cells can support tendon and ligament regeneration, improving outcomes and reducing recovery time.
Conclusion – Supporting Joint Health Naturally
While research continues to refine the most effective ways to use stem cells for joint repair, current evidence highlights the power of Endogenous Stem Cell Mobilization. Using natural stem cell enhancers can:
- Support cartilage, tendon, and ligament repair
- Reduce inflammation and pain
- Improve joint stability and mobility
- Enhance recovery from sports and age-related injuries
Sources:
- Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy – a review.
Freitag J, Bates D, Boyd R, Shah K, Barnard A, Huguenin L, Tenen A.
BMC Musculoskelet Disord. 2016 May 26;17:230. - Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis.
Jorgensen C, Noel D, Apparailly F, Sany J.
Ann Rheum Dis. 2001 Apr;60(4):305-9. - Regenerative approaches for cartilage repair in the treatment of osteoarthritis.
Li MH, Xiao R, Li JB, Zhu Q.
Osteoarthritis Cartilage. 2017 Oct;25(10):1577-1587. - Mesenchymal Stem Cells and Their Clinical Applications in Osteoarthritis.Chang YH, Liu HW, Wu KC, Ding DC.
Cell Transplant. 2016;25(5):937-50. - In Situ Recruitment of Human Bone Marrow-Derived Mesenchymal Stem Cells Using Chemokines for Articular Cartilage Regeneration.
Park MS, Kim YH, Jung Y, Kim SH, Park JC, Yoon DS, Kim SH, Lee JW.
Cell Transplant. 2015;24(6):1067-83. - Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial.
Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS, Ra JC, Oh S, Yoon KS.
Stem Cells. 2014 May;32(5):1254-66. doi: 10.1002/stem.1634. - Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration.
Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K.
Knee Surg Sports Traumatol Arthrosc. 2006 Dec;14(12):1307-14. - Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A.
J Rheumatol. 2004 Mar;31(3):482-8. - The Therapeutic Potential of Stimulating Endogenous Stem Cell Mobilization. In: Tissue Regeneration – From Basic Biology to Clinical Application. Drapeau C, Eufemio G, Mazzoni P, Roth GD and Strandberg, S. InTech Open, 2012.
- Tendon-derived stem/progenitor cell aging: defective self-renewal and altered fate.
Zhou Z, Akinbiyi T, Xu L, Ramcharan M, Leong DJ, Ros SJ, Colvin AC, Schaffler MB, Majeska RJ, Flatow EL, Sun HB.
Aging Cell. 2010 Oct;9(5):911-5. - Mesenchymal Stem Cells Empowering Tendon Regenerative Therapies.
Costa-Almeida R, Calejo I, Gomes ME.
Int J Mol Sci. 2019 Jun 19;20(12). - Study of Bone Marrow Mesenchymal and Tendon-Derived Stem Cells Transplantation on the Regenerating Effect of Achilles Tendon Ruptures in Rats.
Al-Ani MKh, Xu K, Sun Y, Pan L, Xu Z, Yang L.
Stem Cells Int. 2015;2015:984146. - Acute mobilization and migration of bone marrow-derived stem cells following anterior cruciate ligament rupture.
Maerz T, Fleischer M, Newton MD, Davidson A, Salisbury M, Altman P, Kurdziel MD, Anderson K, Bedi A, Baker KC.
Osteoarthritis Cartilage. 2017 Aug;25(8):1335-1344. - The effect of granulocyte-colony stimulating factor on rotator cuff healing after injury and repair.
Ross D, Maerz T, Kurdziel M, Hein J, Doshi S, Bedi A, Anderson K, Baker K.
Clin Orthop Relat Res. 2015 May;473(5):1655-64. - Use of the stem cell mobilizer SE2® as part of conventional treatment on ankle injuries to expedite recovery in professional soccer players.
Garber M, Mazzoni P, Nazir C, AND Drapeau C.
J. Advancement in Medical and Life Sciences, 2(3); 2015.